SlideShare a Scribd company logo
Presented By :
Raisa Imam
TOPIC : MANUFACTURING TECHNIQUE
OF PARENTERAL PRODUCTS
PRESENTATION ON
Manufacturing Technique of Parenteral Products
CONTENT
 Introduction
 Advantages & Disadvantages
 Types
 Formulation
 LVP
 Manufactuing of LVP
 SVP
 Manufacturing of SVP
 LVP VS SVP
 Conclusion
OBJECTIVE
To get introduced with the Manufacturing technique
of Parenteral Preparations.
To get discussed about the process of Parenteral
Preparation Manufacturing
INTRODUCTION
Parenteral
Products
Greek word”
Para” outside
& “Enterone”
Intestine
Administered
directly in the
veins ,
muscles or
under the skin
Term parenteral
used for any
drugfluid whose
delivery doesn’t
utilize the
alimentary canal
Sterile
solutions or
suspension of
drugs in
aqueous or
oily vehicle
Ref:Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage
Forms:Parenterals,Volumes 1.2nd Edition.New Delhi,India:Taylor & Francis,1989p:346-348
Advantages Disadvantages
1.Quick onset 2.Wrong dose or overdose
can be fatal
2.Vomittng and unconscious
patients can take
2.Pain at side
3.Prolonged action modified
formulation (Depot)
3.Trained person required
4.Nutritive fluids can be given 4.Expensive
5.Drugs with poor absorbtion or
instability from GT
5.Necessity of aseptic
conditions in
production,compounding and
administration.
Ref:Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage
Forms:Parentrals,Volumes 1.2nd Edition.New Delhi,India:Taylor &
Francis,1989p:346-348
Classification of Parenteral Preparations :
Ref:Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage
Forms:Tablets,Volumes 1.2nd Edition.New Delhi,India:Taylor &
Francis,1989p:346-348
• Single dose units
• Infusion solution
• Multiple dose units
According to
Packaging dose
units
• Small volume
parenteral (SVP)
• Large volume
parenteral (LVP)
According to
volume
FORMULATION
Active Ingredients
Vehicle
WFI
SWFI
Water
miscible
vehicle
BWFI
Non-
aqous
vehicle
Additiv
e
Antimi
cribial
Antioxi
dent
Buffer
Bufferi
ng
Agents
Chelati
g
Agents
Surfact
ant
Solibuli
zing
Agent
Tonicity
Adjusting
Agent
Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical
Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott
Williams & Wilkins, 2011.Page No:470-473
LARGE-VOLUME PARENTERALS
Lvp are Parenterals designed to provide
Most common LVP’s are 0.9% sodium chloride, dextrose 5% in water,
dextrose 5% in normal saline & LR solution.Volume 101-1000ml
(250ml,500ml & 1000ml mostly)
Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical
Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams &
Wilkins, 2011.Page No:470-473
Fluid
(Water)
Calories
(Dextrose
solution)
Electrolytes
(Saline
Solutin)
Combination
of these
MANUFACTURING OF LVP(SALINE)
BFS
(Blow Fill
and Sealed
Technology )
1.Parison
Extrusion
2..Contai
ner
Molding
3.Contain
er Filling
4.Contain
er
Sealing
BFS
Preservative
free single
dose
Asepctically
manufactured
sterile
product
NO human
intervention,a
utomated.
Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical Dosage
Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams & Wilkins,
2011.Page No:470-473
SMALL VOLUME PARENTERALS
Volume less than 100ml
Usually range 1-30ml in
volume
Mostly given as multiple
dose
Types
Ampul
es
Dry
powder
Prefille
d
Syring
e
Vials
Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical
Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams &
Wilkins, 2011.Page No:470-473
MANUFACTURING OF SVP (AMPULES)
Ingrediants,Vehicles
Compounding of the
product & Filtration of
the solute
Processing
equipments &
cleaning
Container
Component
Cleaning
Sterilization
Filling Sealing
Packing
Product storage
Ref: Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage
Forms:Tablets,Volumes 1.2nd Edition.New Delhi,India:Taylor & Francis,1989p:344-346
MANUFACTURING OF SVP
LVP VS SVP
Parameters SVP LVP
Volume 100ml or less 101-1000ml
Routes IV, IM & SC IV-LVP & non IV-LVP
Dosage Unit Single or multiple Single
Preservative Used Not used
Buffers Used Not used
Formulation Solution,emulsion,sus
pension
Solution & o/w nutrient
emulsion
Isotonicity Not essential Must
Pyrogenicity Not essential Must
Use Therapeutic &
Diagonistic
Nutrition,detoxification
and during surgery
Ref:Jisna Sibastian.Prenteral preparations education blog[Internet]Published
in: Slideshare on Jul 1,2016 available at
https://www.slideshare.net/JisnaSebastian/parenteral-preparationsRef
CONCLUSION
Despite of aseptic
technique in
production,compou
nding and handling
of product this is
the most effective
route for the
delivery of active
pharmaceutical
substances
specially when
drugs cannot be
taken orally
Alternative route
for the drugs that
are highly
hydrophobic as
these drugs
cannot pass
through cell
memrane
08 pn

More Related Content

Similar to 08 pn

Large volume parenterals
Large volume parenteralsLarge volume parenterals
Large volume parenterals
rahul2002
 
Small-Volume Parenteral Preparations
Small-Volume Parenteral Preparations Small-Volume Parenteral Preparations
Small-Volume Parenteral Preparations
Kdurant36
 
Large-Volume Parenteral Preparations
Large-Volume Parenteral Preparations Large-Volume Parenteral Preparations
Large-Volume Parenteral Preparations
Kdurant36
 
NDDS.pptx
NDDS.pptxNDDS.pptx
NDDS.pptx
PritiMittal8
 
Ppt 2011
Ppt 2011Ppt 2011
Ppt 2011
NanoSynergy
 
Nanoemulsion : A versatile drug delivery system
Nanoemulsion : A versatile drug delivery systemNanoemulsion : A versatile drug delivery system
Nanoemulsion : A versatile drug delivery system
DeeptiMSati
 
Clinical trials and drug discovery & development 01-03-2011
Clinical trials and drug discovery & development 01-03-2011Clinical trials and drug discovery & development 01-03-2011
Clinical trials and drug discovery & development 01-03-2011
nadirqureshi996
 
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEMROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
DeepikshaSahu1
 
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEMROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
chandraprakash dwivedi
 
Herbal Drug Delivery System
Herbal Drug Delivery SystemHerbal Drug Delivery System
Herbal Drug Delivery System
Md. Manower Hossain
 
Op RDS
Op RDSOp RDS
Op RDS
om prakash
 
penicillin
penicillin penicillin
penicillin
Laann Swick
 
PARENTRAL DOSAGE FORM OR STERILE DOSAGE FORM
PARENTRAL DOSAGE FORM OR  STERILE DOSAGE FORMPARENTRAL DOSAGE FORM OR  STERILE DOSAGE FORM
PARENTRAL DOSAGE FORM OR STERILE DOSAGE FORM
avinash thalkari
 
NTR 340 Nutrition Research Questionnaire- USE ME(1)
NTR 340 Nutrition Research Questionnaire- USE ME(1)NTR 340 Nutrition Research Questionnaire- USE ME(1)
NTR 340 Nutrition Research Questionnaire- USE ME(1)
Laurie Hill
 
Xenobiotic 24 12-15
Xenobiotic 24 12-15Xenobiotic 24 12-15
Xenobiotic 24 12-15
Daisy Kameng Baruah
 
Advances in pharmacy
Advances in pharmacyAdvances in pharmacy
Advances in pharmacy
bandaru pratyusha
 
Enzymes
EnzymesEnzymes
Enzymes
Lisa Kennedy
 
Iv admixtures PPT
Iv admixtures PPTIv admixtures PPT
Iv admixtures PPT
Asif Mehmood Hashmi
 
Celerion_050515_TIDES_Intranasal-Drug-Delivery (1).pdf
Celerion_050515_TIDES_Intranasal-Drug-Delivery (1).pdfCelerion_050515_TIDES_Intranasal-Drug-Delivery (1).pdf
Celerion_050515_TIDES_Intranasal-Drug-Delivery (1).pdf
Natasha313161
 
Industrial production of pencillin
Industrial production of pencillinIndustrial production of pencillin
Industrial production of pencillin
NARTHANAA SENAVARAYAN
 

Similar to 08 pn (20)

Large volume parenterals
Large volume parenteralsLarge volume parenterals
Large volume parenterals
 
Small-Volume Parenteral Preparations
Small-Volume Parenteral Preparations Small-Volume Parenteral Preparations
Small-Volume Parenteral Preparations
 
Large-Volume Parenteral Preparations
Large-Volume Parenteral Preparations Large-Volume Parenteral Preparations
Large-Volume Parenteral Preparations
 
NDDS.pptx
NDDS.pptxNDDS.pptx
NDDS.pptx
 
Ppt 2011
Ppt 2011Ppt 2011
Ppt 2011
 
Nanoemulsion : A versatile drug delivery system
Nanoemulsion : A versatile drug delivery systemNanoemulsion : A versatile drug delivery system
Nanoemulsion : A versatile drug delivery system
 
Clinical trials and drug discovery & development 01-03-2011
Clinical trials and drug discovery & development 01-03-2011Clinical trials and drug discovery & development 01-03-2011
Clinical trials and drug discovery & development 01-03-2011
 
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEMROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
 
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEMROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
ROLE OF LIPOSOME IN NOVEL DRUG DELIVERY SYSTEM
 
Herbal Drug Delivery System
Herbal Drug Delivery SystemHerbal Drug Delivery System
Herbal Drug Delivery System
 
Op RDS
Op RDSOp RDS
Op RDS
 
penicillin
penicillin penicillin
penicillin
 
PARENTRAL DOSAGE FORM OR STERILE DOSAGE FORM
PARENTRAL DOSAGE FORM OR  STERILE DOSAGE FORMPARENTRAL DOSAGE FORM OR  STERILE DOSAGE FORM
PARENTRAL DOSAGE FORM OR STERILE DOSAGE FORM
 
NTR 340 Nutrition Research Questionnaire- USE ME(1)
NTR 340 Nutrition Research Questionnaire- USE ME(1)NTR 340 Nutrition Research Questionnaire- USE ME(1)
NTR 340 Nutrition Research Questionnaire- USE ME(1)
 
Xenobiotic 24 12-15
Xenobiotic 24 12-15Xenobiotic 24 12-15
Xenobiotic 24 12-15
 
Advances in pharmacy
Advances in pharmacyAdvances in pharmacy
Advances in pharmacy
 
Enzymes
EnzymesEnzymes
Enzymes
 
Iv admixtures PPT
Iv admixtures PPTIv admixtures PPT
Iv admixtures PPT
 
Celerion_050515_TIDES_Intranasal-Drug-Delivery (1).pdf
Celerion_050515_TIDES_Intranasal-Drug-Delivery (1).pdfCelerion_050515_TIDES_Intranasal-Drug-Delivery (1).pdf
Celerion_050515_TIDES_Intranasal-Drug-Delivery (1).pdf
 
Industrial production of pencillin
Industrial production of pencillinIndustrial production of pencillin
Industrial production of pencillin
 

Recently uploaded

Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 

Recently uploaded (20)

Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 

08 pn

  • 1. Presented By : Raisa Imam TOPIC : MANUFACTURING TECHNIQUE OF PARENTERAL PRODUCTS
  • 3. CONTENT  Introduction  Advantages & Disadvantages  Types  Formulation  LVP  Manufactuing of LVP  SVP  Manufacturing of SVP  LVP VS SVP  Conclusion
  • 4. OBJECTIVE To get introduced with the Manufacturing technique of Parenteral Preparations. To get discussed about the process of Parenteral Preparation Manufacturing
  • 5. INTRODUCTION Parenteral Products Greek word” Para” outside & “Enterone” Intestine Administered directly in the veins , muscles or under the skin Term parenteral used for any drugfluid whose delivery doesn’t utilize the alimentary canal Sterile solutions or suspension of drugs in aqueous or oily vehicle Ref:Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage Forms:Parenterals,Volumes 1.2nd Edition.New Delhi,India:Taylor & Francis,1989p:346-348
  • 6. Advantages Disadvantages 1.Quick onset 2.Wrong dose or overdose can be fatal 2.Vomittng and unconscious patients can take 2.Pain at side 3.Prolonged action modified formulation (Depot) 3.Trained person required 4.Nutritive fluids can be given 4.Expensive 5.Drugs with poor absorbtion or instability from GT 5.Necessity of aseptic conditions in production,compounding and administration. Ref:Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage Forms:Parentrals,Volumes 1.2nd Edition.New Delhi,India:Taylor & Francis,1989p:346-348
  • 7. Classification of Parenteral Preparations : Ref:Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage Forms:Tablets,Volumes 1.2nd Edition.New Delhi,India:Taylor & Francis,1989p:346-348 • Single dose units • Infusion solution • Multiple dose units According to Packaging dose units • Small volume parenteral (SVP) • Large volume parenteral (LVP) According to volume
  • 8. FORMULATION Active Ingredients Vehicle WFI SWFI Water miscible vehicle BWFI Non- aqous vehicle Additiv e Antimi cribial Antioxi dent Buffer Bufferi ng Agents Chelati g Agents Surfact ant Solibuli zing Agent Tonicity Adjusting Agent Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams & Wilkins, 2011.Page No:470-473
  • 9. LARGE-VOLUME PARENTERALS Lvp are Parenterals designed to provide Most common LVP’s are 0.9% sodium chloride, dextrose 5% in water, dextrose 5% in normal saline & LR solution.Volume 101-1000ml (250ml,500ml & 1000ml mostly) Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams & Wilkins, 2011.Page No:470-473 Fluid (Water) Calories (Dextrose solution) Electrolytes (Saline Solutin) Combination of these
  • 10. MANUFACTURING OF LVP(SALINE) BFS (Blow Fill and Sealed Technology ) 1.Parison Extrusion 2..Contai ner Molding 3.Contain er Filling 4.Contain er Sealing BFS Preservative free single dose Asepctically manufactured sterile product NO human intervention,a utomated. Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams & Wilkins, 2011.Page No:470-473
  • 11.
  • 12. SMALL VOLUME PARENTERALS Volume less than 100ml Usually range 1-30ml in volume Mostly given as multiple dose Types Ampul es Dry powder Prefille d Syring e Vials Ref: Allen V. Lloyd,Popovich G. Nicholas,Ansel C. Howard. Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems.9th edition. Chicago,U.S.:Lippincott Williams & Wilkins, 2011.Page No:470-473
  • 13. MANUFACTURING OF SVP (AMPULES) Ingrediants,Vehicles Compounding of the product & Filtration of the solute Processing equipments & cleaning Container Component Cleaning Sterilization Filling Sealing Packing Product storage Ref: Avis E. Kennet,Liberman Herbert,Lachman Leon.Pharmaceutical Dosage Forms:Tablets,Volumes 1.2nd Edition.New Delhi,India:Taylor & Francis,1989p:344-346
  • 15. LVP VS SVP Parameters SVP LVP Volume 100ml or less 101-1000ml Routes IV, IM & SC IV-LVP & non IV-LVP Dosage Unit Single or multiple Single Preservative Used Not used Buffers Used Not used Formulation Solution,emulsion,sus pension Solution & o/w nutrient emulsion Isotonicity Not essential Must Pyrogenicity Not essential Must Use Therapeutic & Diagonistic Nutrition,detoxification and during surgery Ref:Jisna Sibastian.Prenteral preparations education blog[Internet]Published in: Slideshare on Jul 1,2016 available at https://www.slideshare.net/JisnaSebastian/parenteral-preparationsRef
  • 16. CONCLUSION Despite of aseptic technique in production,compou nding and handling of product this is the most effective route for the delivery of active pharmaceutical substances specially when drugs cannot be taken orally Alternative route for the drugs that are highly hydrophobic as these drugs cannot pass through cell memrane